Telemedicine

MaNaDr must ensure regulatory compliance regardless of its corporate structure: MOH

The company telehealth platform provides healthcare services via its network of 700 clinics and more than 1,500 medical professionals in Singapore

Investigations into the other five providers are ongoing.

Eight telemed providers, including MaNaDr, investigated for regulatory breaches: Janil

Investigations into three of the cases have been completed, resulting in enforcement action

A brief look at the MaNaDr app or website reveals little change.
COMMENTARY

With its teleconsultation platform intact, revoking MaNaDr’s licence could have little impact

Telemedicine revenue accounts for about US$12.8 million or 90.4% of its parent company’s total sales

The ministry earlier issued a notice of intent to revoke MaNaDr’s licence on Oct 24.

MaNaDr Clinic loses licence, found to have ‘entrenched culture of disregard’ for ethical and clinical standards: MOH

The clinic can no longer operate at its permanent premises at 371 Beach Road, nor temporary locations such as patients’ residences, or remotely via teleconsultation

Friday’s circular was issued by the Ministry of Health, the Health Sciences Authority and the Singapore Medical Council.

Clinics warned to get their act together over telehealth, advertising abuses

This includes ensuring teleconsultations are appropriate for patient’s condition, not promoting prescription-only medicines

The Singapore Medical Council's Ethical Code and Ethical Guidelines only apply to individual doctors, not telemedicine providers.

Ads by telemedicine providers do not fall under Singapore Medical Council purview

They will only be in breach of guidelines if they are put up by individual registered doctors

The ads for GLP-1 drugs, such as Saxenda, have gained attention for their effectiveness in aiding weight loss.

Singapore authorities now reviewing telemed providers’ ads for weight-loss drugs

Lawyers say such advertisements may contravene a ban on ads for prescription medications

On Oct 24, MOH announced its intention to revoke MaNaDr’s licence. Minister Ong notes that the regulatory action followed public complaints.

Telemedicine regulations remain valid, no review needed despite MaNaDr case: Ong Ye Kung

Existing rules, coupled with public feedback, enable prompt action against offenders, says minister

MaNaDr’s consultations were priced from S$8.20, lower than the typical S$20 to S$25 charged at physical clinics.

MaNaDr’s low prices could have encouraged too-brief teleconsultations: doctors

Smaller medical fees mean reduced takings for doctors, which may have caused them to prioritise volume over clinical standards

On Oct 24, MOH said it intended to revoke MaNaDr Clinic’s licence.
COMMENTARY

MaNaDr’s exit highlights need for tighter telemedicine audits

Government oversight will set expectations and allow for earlier flagging of errant behaviour